Patents by Inventor Danae D. Christodoulou

Danae D. Christodoulou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5603820
    Abstract: An electrode sensor which may be used to specifically and quantitatively measure nitric oxide is provided, as well as a method of preparing and using such an electrode sensor to measure nitric oxide concentration in solution. A nitric oxide (NO) microsensor based on catalytic oxidation of NO comprises a thermally-sharpened carbon fiber with a tip diameter of about 0.5-0.7 .mu.m coated with several layers of p-type semiconducting polymeric porphyrin and cationic exchanger deposited thereon. The microsensor, which can be operated in either the amperometric, voltammetric or coulometric mode utilizing a two or three electrode system, is characterized by a linear response up to about 300 .mu.M, a response time better than 10 msec and a detection limit of about 10 nM. The sensor of the present invention also discriminates against nitrite, the most problematic interferant in NO measurements.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 18, 1997
    Assignees: The United States of America as represented by the Department of Health and Human Services, The University of North Carolina at Chapel Hill
    Inventors: Tadeusz Malinski, David A. Wink, Janet Younathan, Royce W. Murray, Melani Sullivan, Thomas J. Meyer, Danae D. Christodoulou
  • Patent number: 5389675
    Abstract: Mixed ligand metal complexes of nitric oxide-nucleophile adducts, useful as cardiovascular agents of the formula KA, wherein A is[(M).sub.x.sup.x' (L).sub.y (R.sup.1 R.sup.2 N-N.sub.2 O.sub.2).sub.x ], andK is a pharmaceutically acceptable counterion present in the composition when the overall charge of A is not zero, counterion K being present only in an amount to neutralize A. Methods of treating mammals with such compounds are provided. Pharmaceutical compositions containing such compounds are also provided.
    Type: Grant
    Filed: March 27, 1992
    Date of Patent: February 14, 1995
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Danae D. Christodoulou, David A. Wink, Jr., Larry K. Keefer